Aflumicot

Aflumicot may be available in the countries listed below.

Ingredient matches for Aflumicot

Fluconazole

Fluconazole is reported as an ingredient of Aflumicot in the following countries:

• Venezuela

International Drug Name Search

Thiocolchicoside G Gam

Thiocolchicoside G Gam may be available in the countries listed below.

Ingredient matches for Thiocolchicoside G Gam

Thiocolchicoside

Thiocolchicoside is reported as an ingredient of Thiocolchicoside G Gam in the following countries:

• France

International Drug Name Search

Pandel

Pandel is a brand name of hydrocortisone topical, approved by the FDA in the following formulation(s):

PANDEL (hydrocortisone probutate - cream; topical)

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: February 28, 1997
  
  Strength(s): 0.1% ^[RLD]

Has a generic version of Pandel been approved?

No. There is currently no therapeutically equivalent version of Pandel available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pandel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Pandel.

See also...

• Pandel Consumer Information (Cerner Multum)
• Pandel Topical application Advanced Consumer Information (Micromedex)
• Hemorrhoidal-HC Suppositories Consumer Information (Wolters Kluwer)
• Hydrocortisone Acetate Suppositories Consumer Information (Wolters Kluwer)
• Hydrocortisone Butyrate Solution Consumer Information (Wolters Kluwer)
• Hydrocortisone Cream Consumer Information (Wolters Kluwer)
• Hydrocortisone Foam Consumer Information (Wolters Kluwer)
• Hydrocortisone Gel Consumer Information (Wolters Kluwer)
• Hydrocortisone Lotion Consumer Information (Wolters Kluwer)
• Hydrocortisone rectal cream, ointment, suppository Consumer Information (Cerner Multum)
• Hydrocortisone topical Consumer Information (Cerner Multum)
• Anusol HC Advanced Consumer Information (Micromedex)
• Barriere-Hc Topical application Advanced Consumer Information (Micromedex)
• Cort-Eze Topical application Advanced Consumer Information (Micromedex)
• Corta-Cap Advanced Consumer Information (Micromedex)
• Cortagel Extra Strength Advanced Consumer Information (Micromedex)
• Cortate Topical application Advanced Consumer Information (Micromedex)
• Corticool Maximum Strength Advanced Consumer Information (Micromedex)
• Cortoderm Mild Ointment Topical application Advanced Consumer Information (Micromedex)
• Cortoderm Regular Ointment Topical application Advanced Consumer Information (Micromedex)
• Delacort Advanced Consumer Information (Micromedex)
• Dermarest Advanced Consumer Information (Micromedex)
• Emo-Cort Scalp Solution Topical application Advanced Consumer Information (Micromedex)
• Emo-Cort Topical application Advanced Consumer Information (Micromedex)
• Foille Cort Advanced Consumer Information (Micromedex)
• Hydrocortisone Cream Topical application Advanced Consumer Information (Micromedex)
• Hydroval Advanced Consumer Information (Micromedex)
• Hydrozone Plus Advanced Consumer Information (Micromedex)
• Instacort-10 Advanced Consumer Information (Micromedex)
• Ivy Soothe Advanced Consumer Information (Micromedex)
• IvyStat Advanced Consumer Information (Micromedex)
• Keratol HC Advanced Consumer Information (Micromedex)
• Kericort 10 Advanced Consumer Information (Micromedex)
• Medi-Cortisone Maximum Strength Advanced Consumer Information (Micromedex)
• Microcort Advanced Consumer Information (Micromedex)
• Mycin Scalp Advanced Consumer Information (Micromedex)
• Neutrogena T/Scalp Advanced Consumer Information (Micromedex)
• Novo-Hydrocort Cream Topical application Advanced Consumer Information (Micromedex)
• Novo-Hydrocort Topical application Advanced Consumer Information (Micromedex)
• NuCort Advanced Consumer Information (Micromedex)
• Nupercainal HC Advanced Consumer Information (Micromedex)
• Pediaderm HC Kit Advanced Consumer Information (Micromedex)
• Prevex Hc Topical application Advanced Consumer Information (Micromedex)
• Sarna Hc Topical application Advanced Consumer Information (Micromedex)
• Sarnol-HC Maximum Strength Advanced Consumer Information (Micromedex)
• Summer's Eve Specialcare Advanced Consumer Information (Micromedex)
• Tarocort Advanced Consumer Information (Micromedex)
• Therasoft Anti-Itch & Dermatitis Advanced Consumer Information (Micromedex)
• Hydrocortisone Topical application Advanced Consumer Information (Micromedex)
• Hydrocortisone butyrate Topical application Advanced Consumer Information (Micromedex)
• Hydrocortisone probutate Topical application Advanced Consumer Information (Micromedex)
• Hydrocortisone valerate Topical application Advanced Consumer Information (Micromedex)
• Hydrocortisone Acetate topical AHFS DI Monographs (ASHP)
• Hydrocortisone Buteprate topical AHFS DI Monographs (ASHP)
• Hydrocortisone Butyrate topical AHFS DI Monographs (ASHP)
• Hydrocortisone Valerate topical AHFS DI Monographs (ASHP)
• Hydrocortisone topical AHFS DI Monographs (ASHP)

Tasigna

Tasigna is a brand name of nilotinib, approved by the FDA in the following formulation(s):

TASIGNA (nilotinib hydrochloride monohydrate - capsule; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: October 29, 2007
  
  Strength(s): EQ 200MG BASE ^[RLD]


• 
  Manufacturer: NOVARTIS
  
  Approval date: June 17, 2010
  
  Strength(s): EQ 150MG BASE
  

Has a generic version of Tasigna been approved?

No. There is currently no therapeutically equivalent version of Tasigna available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tasigna. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Inhibitors of tyrosine kinases
  Patent 7,169,791
  Issued: January 30, 2007
  Inventor(s): Breitenstein; Werner & Furet; Pascal & Jacob; Sandra & Manley; Paul William
  Assignee(s): Novartis AG
  The invention relates to compounds of formula wherein the substituents R1, R2 and R4 have the meaning as set forth and explained in the description of the invention, to processes for the preparation of these compounds, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease, in particular leukaemia, and a method for the treatment of such a disease.
  
  Patent expiration dates:
  
  
  • July 4, 2023
    
    ✓ 
    Patent use: A METHOD FOR THE TREATMENT OF LEUKEMIAS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 29, 2012 - NEW CHEMICAL ENTITY
  
  
  • June 17, 2013 - TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH & CML) IN CHRONIC PHASE.
  
  
  • June 17, 2014 - TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH & CML) IN CHRONIC PHASE.
  
  
  • October 29, 2014 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Tasigna Consumer Information (Drugs.com)
• Tasigna Consumer Information (Wolters Kluwer)
• Tasigna Consumer Information (Cerner Multum)
• Tasigna Advanced Consumer Information (Micromedex)
• Tasigna AHFS DI Monographs (ASHP)
• Nilotinib Consumer Information (Wolters Kluwer)
• Nilotinib Consumer Information (Cerner Multum)
• Nilotinib Advanced Consumer Information (Micromedex)
• Nilotinib AHFS DI Monographs (ASHP)

Tobrasol

In the US, Tobrasol (tobramycin ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Conjunctivitis, Bacterial.

US matches:

• Tobrasol

Ingredient matches for Tobrasol

Tobramycin

Tobramycin is reported as an ingredient of Tobrasol in the following countries:

• Venezuela

International Drug Name Search

Potasyum Fosfat

Potasyum Fosfat may be available in the countries listed below.

Ingredient matches for Potasyum Fosfat

Potassium Citrate

Potassium Citrate is reported as an ingredient of Potasyum Fosfat in the following countries:

• Turkey

International Drug Name Search

Fospropofol Disodium

Fospropofol Disodium may be available in the countries listed below.

Ingredient matches for Fospropofol Disodium

Fospropofol

Fospropofol Disodium (USAN) is known as Fospropofol in the US.

International Drug Name Search

Glossary

USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Gascon

Gascon may be available in the countries listed below.

Ingredient matches for Gascon

Dimeticone

Dimeticone is reported as an ingredient of Gascon in the following countries:

• China


• Hong Kong


• Japan


• Taiwan

International Drug Name Search

Penicillin G Potassium

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Penicillin G Potassium

Benzylpenicillin

Benzylpenicillin is reported as an ingredient of Penicillin G Potassium in the following countries:

• United States

Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin G Potassium in the following countries:

• Ethiopia


• Japan


• United States

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin G Potassium in the following countries:

• United States

International Drug Name Search